UNSPSC 51402404: Prazitone hydrochloride

This classification denotes an antidepressant agent C16H19N3O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1N7P630564, chemically known as barbituric acid, 5-phenyl-5-(2-piperidylmethyl)-, monohydrochloride, but more generally known as prazitone hydrochloride, which bears US NIH Compound Identifier 24845095. European Medicines Agency schedules Prazitone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04012MIG.

Most nations, for tariff and trade purposes, schedule prazitone hydrochloride under HS 29335400 and SITC kg. As of Q4 2014, PRAZITONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)C2(C(=O)NC(=O)NC2=O)CC3CCCCN3.CL.

UNSPSC 51402404 Prazitone hydrochloride is a Commodity code that nominally designates a specific pharmaceutical active ingredient, but recent state and local solicitation activity under this code shows little alignment with the code's stated scope. The single recent opportunity on record — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits naloxone and safe drug deactivation systems for community health initiatives, neither of which is prazitone hydrochloride. The county is seeking 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs in their proposals, maintain workers' compensation and general liability insurance, comply with E-Verify requirements, and accept a three-month probationary termination period. The contract carries a two-year initial term with a one-year renewal option and may be funded through FEMA, triggering additional federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act.

This code shows minimal recent state and local procurement activity, and the single opportunity posted carries a substantive mismatch between the code's pharmaceutical designation and the actual goods being purchased. Geographic activity is limited to Florida. Business development professionals should treat this code as inactive for practical procurement purposes and verify the correct UNSPSC designation if naloxone or drug deactivation systems are the intended product focus.